Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PHIO PHARMACEUTICALS CORP.

(PHIO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Largely Sitting Out Markets Recovery This Afternoon

09/16/2021 | 03:38pm EST


ę MT Newswires 2021
All news about PHIO PHARMACEUTICALS CORP.
11/15Phio Pharmaceuticals Presents Positive New Data On Systemic Immune Response After Local..
AQ
11/12Phio Pharmaceuticals Presents Positive New Data On Systemic Immune Response After Local..
PR
11/10Phio Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business..
PU
11/10Phio Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business..
PR
11/10PHIO PHARMACEUTICALS CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
11/10Phio Pharmaceuticals Corp. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
10/18PHIO PHARMACEUTICALS : Announces Upcoming Presentation at the SITC 36th Annual Meeting
PR
10/07PHIO PHARMACEUTICALS : Presents New BRD4 Data at the AACR-NCI-EORTC International Conferen..
PR
09/30PHIO PHARMACEUTICALS : Announces Two Upcoming Data Presentations at Scientific Conferences..
PR
09/16US Stocks Mostly Lower Thursday After Surprise Retail Sales Gain, Rise in Jobless Claim..
MT
More news
Analyst Recommendations on PHIO PHARMACEUTICALS CORP.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -14,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,12x
Yield 2021 -
Capitalization 16,8 M 16,8 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 0,34x
Nbr of Employees 10
Free-Float 99,7%
Chart PHIO PHARMACEUTICALS CORP.
Duration : Period :
Phio Pharmaceuticals Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHIO PHARMACEUTICALS CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,24 $
Average target price 6,00 $
Spread / Average Target 384%
EPS Revisions
Managers and Directors
Gerrit Dispersyn President, Chief Executive Officer & Director
Caitlin Kontulis Secretary, VP-Finance & Administration
Robert J. Bitterman Chairman
Simon Fricker Vice President-Research
James Cardia Vice President-Business Operations
Sector and Competitors
1st jan.Capi. (M$)
PHIO PHARMACEUTICALS CORP.-51.67%17
MODERNA, INC.188.59%122 239
LONZA GROUP AG25.98%57 878
IQVIA HOLDINGS INC.46.64%50 192
SEAGEN INC.-9.40%29 014
CELLTRION, INC.-40.67%24 745